Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Orchestra BioMed Holdings, Inc. | Executive Vice President, Corporate Development & Strategy | Common Stock, par value $0.0001 per share ("Common Stock") | 308K | $2.16M | $7.00 | May 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OBIO | Orchestra BioMed Holdings, Inc. | May 30, 2024 | 1 | $28K | 4 | Jun 3, 2024 | Executive Vice President, Corporate Development & Strategy |
OBIO | Orchestra BioMed Holdings, Inc. | May 8, 2024 | 1 | $0 | 4 | May 10, 2024 | Executive Vice President, Corporate Development & Strategy |
OBIO | Orchestra BioMed Holdings, Inc. | Jul 20, 2023 | 1 | $0 | 4 | Jul 24, 2023 | Executive Vice President, Corporate Development & Strategy |
OBIO | Orchestra BioMed Holdings, Inc. | Jun 1, 2023 | 0 | $0 | 3 | Jun 12, 2023 | Executive Vice President, Corporate Development & Strategy Exhibit 24 - Power of Attorney |